Traws Pharma, Inc.

Traws Pharma, Inc.verified

TRAW

Price:

$2.36

Market Cap:

$11.25M

Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the re...[Read more]

Industry

Biotechnology

IPO Date

Stock Exchange

NASDAQ

Ticker

TRAW

The Enterprise Value as of December 2025 (TTM) for Traws Pharma, Inc. (TRAW) is 4.83M

According to Traws Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.83M. This represents a change of -161.33% compared to the average of -7874435.38 of the last 4 quarters.

Traws Pharma, Inc. (TRAW) Historical Enterprise Value (quarterly & annually)

How has TRAW Enterprise Value performed in the past?

The mean historical Enterprise Value of Traws Pharma, Inc. over the last ten years is -1259535.21. The current 4.83M Enterprise Value has changed -38445.25% with respect to the historical average. Over the past ten years (40 quarters), TRAW's Enterprise Value was at its highest in in the June 2013 quarter at 10.19B. The Enterprise Value was at its lowest in in the December 2022 quarter at -25155116.25.

Quarterly (TTM)
Annual

Average

-1259535.21

Median

-7909390.47

Minimum

-25166653.75

Maximum

62.77M

Traws Pharma, Inc. (TRAW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Traws Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 108.74%

Maximum Annual Enterprise Value = 62.77M

Minimum Annual Increase = -661.33%

Minimum Annual Enterprise Value = -25166653.75

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-7550157.2048.64%
2023-5079362.50-79.82%
2022-25166653.75107.17%
2021-12147953.75-119.35%
202062.77M-463.68%
2019-17259985.00108.74%
2018-8268623.75-187.26%
20179.48M-183.11%
2016-11401529.53-661.33%
20152.03M-92.66%

Traws Pharma, Inc. (TRAW) Average Enterprise Value

How has TRAW Enterprise Value performed in the past?

The current Enterprise Value of Traws Pharma, Inc. (TRAW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12598724.48

5-year avg

2.57M

10-year avg

-1259535.21

Traws Pharma, Inc. (TRAW) Enterprise Value vs. Peers

How is TRAW’s Enterprise Value compared to its peers?

Traws Pharma, Inc.’s Enterprise Value is greater than Cingulate Inc. (-4702578210.00), greater than Dogwood Therapeutics, Inc. (1.78M), less than Imunon, Inc. (1.11B), greater than Cocrystal Pharma, Inc. (4.46M), greater than Sensei Biotherapeutics, Inc. (4.78M), less than Bolt Biotherapeutics, Inc. (16.02M), greater than Mustang Bio, Inc. (-3022675.00), less than Evogene Ltd. (13.64M), less than BioRestorative Therapies, Inc. (7.90M), less than Immuron Limited (13.82M),

Build a custom stock screener for Traws Pharma, Inc. (TRAW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Traws Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Traws Pharma, Inc. (TRAW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Traws Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Traws Pharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Traws Pharma, Inc. (TRAW)?

What is the 3-year average Enterprise Value for Traws Pharma, Inc. (TRAW)?

What is the 5-year average Enterprise Value for Traws Pharma, Inc. (TRAW)?

How does the current Enterprise Value for Traws Pharma, Inc. (TRAW) compare to its historical average?